|
PARK14
MCID: PRK071
MIFTS: 48
|
Parkinson Disease 14, Autosomal Recessive (PARK14)
Categories:
Genetic diseases, Mental diseases, Metabolic diseases, Muscle diseases, Neuronal diseases, Rare diseases
|
|
|
|
MalaCards integrated aliases for Parkinson Disease 14, Autosomal Recessive:
Characteristics:Orphanet epidemiological data:58
adult-onset dystonia-parkinsonism
Inheritance: Autosomal recessive; Prevalence: <1/1000000 (Worldwide); Age of onset: Adolescent,Adult; OMIM:56
Miscellaneous:
rapidly progressive onset in young adulthood favorable initial response to l-dopa foot dragging may appear in childhood l-dopa-induced dyskinesias
Inheritance:
autosomal recessive HPO:31
parkinson disease 14, autosomal recessive:
Inheritance autosomal recessive inheritance Onset and clinical course rapidly progressive Classifications:
MalaCards categories:
Global: Genetic diseases Rare diseases Metabolic diseases Anatomical: Neuronal diseases Muscle diseases Mental diseases
ICD10:
33
Orphanet: 58
Rare neurological diseases
Inborn errors of metabolism External Ids:
|
|
NIH Rare Diseases :
52
The following summary is from Orphanet , a European reference portal for information on rare diseases and orphan drugs. Orpha Number: 199351 Definition A rare neurodegenerative disease usually presenting before the age of 30 and which is characterized by dystonia , L-dopa-responsive parkinsonism, pyramidal signs and rapid cognitive decline. Epidemiology Prevalence is unknown. Only 14 cases have been reported to date. Clinical description Disease onset occurs in late adolescence or early adulthood (usually before the age of 30) and usually presents with parkinsonism (tremor, rigidity, bradykinesia), dystonia and rapid cognitive decline. Eye movement abnormalities (supranuclear vertical gaze palsy, eyelid opening apraxia), pyramidal tract signs, and psychiatric features such as depression and personality changes have also been reported in some patients. Dopaminergic treatment is initially successful with regard to parkinsonism, but the development of prominent dyskinesias often follows. Etiology Adult-onset dystonia-parkinsonism is caused by mutations in the phospholipase A2, group VI (PLA2G6 ) gene located on chromosome 22q13.1. Genetic counseling Adult-onset dystonia-parkinsonism is inherited in an autosomal recessive manner, and genetic counseling is possible and recommended. Visit the Orphanet disease page for more resources.
MalaCards based summary : Parkinson Disease 14, Autosomal Recessive, also known as parkinson disease 14, is related to neurodegeneration with brain iron accumulation 2a and early-onset parkinson's disease, and has symptoms including tremor, abnormality of extrapyramidal motor function and clumsiness. An important gene associated with Parkinson Disease 14, Autosomal Recessive is PLA2G6 (Phospholipase A2 Group VI), and among its related pathways/superpathways are G alpha (s) signalling events and GPCRs, Class B Secretin-like. The drugs Clotrimazole and Miconazole have been mentioned in the context of this disorder. Affiliated tissues include eye and brain, and related phenotypes are spasticity and dysphagia Disease Ontology : 12 A late-onset Parkinson disease that has material basis in homozygous mutation in the PLA2G6 gene on chromosome 22q13. UniProtKB/Swiss-Prot : 73 Parkinson disease 14: An adult-onset progressive neurodegenerative disorder characterized by parkinsonism, dystonia, severe cognitive decline, cerebral and cerebellar atrophy and absent iron in the basal ganglia on magnetic resonance imaging. |
Human phenotypes related to Parkinson Disease 14, Autosomal Recessive:58 31 (show all 39)
Symptoms via clinical synopsis from OMIM:56Clinical features from OMIM:612953UMLS symptoms related to Parkinson Disease 14, Autosomal Recessive:tremor, abnormality of extrapyramidal motor function, clumsiness, personality changes, bradykinesia, muscle rigidity, muscle spasticity GenomeRNAi Phenotypes related to Parkinson Disease 14, Autosomal Recessive according to GeneCards Suite gene sharing:26
MGI Mouse Phenotypes related to Parkinson Disease 14, Autosomal Recessive:45
|
Drugs for Parkinson Disease 14, Autosomal Recessive (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):(show all 9)
Interventional clinical trials:
Cochrane evidence based reviews: dystonia-parkinsonism, adult-onset |
MalaCards organs/tissues related to Parkinson Disease 14, Autosomal Recessive:40
Eye,
Brain
|
Articles related to Parkinson Disease 14, Autosomal Recessive:(show all 33)
|
Genes related to Parkinson Disease 14, Autosomal Recessive (1 elite genes): - Elite gene
- Cancer Census gene in COSMIC
|
ClinVar genetic disease variations for Parkinson Disease 14, Autosomal Recessive:6 (show all 15)
UniProtKB/Swiss-Prot genetic disease variations for Parkinson Disease 14, Autosomal Recessive:73
|
|
Search
GEO
for disease gene expression data for Parkinson Disease 14, Autosomal Recessive.
|
Cellular components related to Parkinson Disease 14, Autosomal Recessive according to GeneCards Suite gene sharing:
Biological processes related to Parkinson Disease 14, Autosomal Recessive according to GeneCards Suite gene sharing:
Molecular functions related to Parkinson Disease 14, Autosomal Recessive according to GeneCards Suite gene sharing:
|
|